Susanna Naggie, MD, MHS, on HCV and HIV coinfection FAQs and challenges. Guideline-based strategies, common DAA and ART drug interactions (DDIs).
Tool, education to avoid drug interactions, follow guidelines when choosing anti-HCV DAA and anti-HIV ART drugs for patients with HCV/HIV coinfection.
Downloadable slides from Mark S. Sulkowski, MD, on selecting optimal DAA and antiretroviral combinations for patients with HCV/HIV coinfection.
CME-certified education from Mark S. Sulkowski, MD, on choosing HCV and antiretroviral regimens for patients with HCV/HIV coinfection.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.